Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2026-01-24 @ 9:36 PM
Study NCT ID:
NCT01442168
Status:
TERMINATED
Last Update Posted:
2014-08-19
First Post:
2011-09-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria
Sponsor:
Modus Therapeutics AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Sevuparin/DF02_TSM02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |